News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urigen N.A. Announces Phase 2 Results For U101 In Chronic Pelvic Pain


10/31/2006 11:09:55 AM

BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc. reported that U101 did not meet the primary endpoint in a Phase 2 clinical study in Chronic Pelvic Pain of bladder origin. However, the Company believes the trial provided the information necessary to proceed with development of the product.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES